Rizatriptan benzoate
Rizatriptan Benzoate is a prescription medication used to treat migraine headaches. It comes as orally disintegrating tablets in 5mg and 10mg strengths, taken by mouth. As a serotonin receptor agonist, it helps relieve migraine symptoms like pain and nausea. Manufactured by Aurobindo Pharma Ltd. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Rizatriptan Benzoate is a prescription medication used to treat migraine headaches. It comes as orally disintegrating tablets in 5mg and 10mg strengths, taken by mouth. As a serotonin receptor agonist, it helps relieve migraine symptoms like pain and nausea. Manufactured by Aurobindo Pharma Ltd. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Rizatriptan benzoate",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Rizatriptan benzoate — ANDA 204339 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204339"
}
]
|
| identifier | ANDA204339 |
| issued | 2016-09-16 |
| keyword |
[
"drug-information",
"fda",
"health-care",
"medications",
"pharmaceuticals"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Rizatriptan benzoate |
